Kneeland Youngblood, M.D., Chairman of the Board
Kneeland has extensive investment experience, having served from 1993 to 1999 on the board of the $100 billion Teacher Retirement system of Texas (TRS). In his capacity as a trustee, he was actively involved in hiring investment advisors, determining asset allocations and formulating investment/benefit policies. He served as chairman of the Fund's Real Estate Committee, where he directed a major restructuring of the $1.4 billion portfolio. He also served on the Board of Directors and developed direct private equity experience with the Texas Growth Fund, a $500 million private equity fund providing growth and expansion capital. Mr. Youngblood is also a Chairman of the board of the American Beacon Funds, a $20 billion investment affiliate of American Airlines. Mr. Youngblood's other board memberships include: Burger King, Starwood Hotels and Resorts and the City of Dallas Employee Retirement System. He is also a Director Emeritus of iStar Financial, a NYSE publicly traded REIT, and a Director Emeritus of the U.S. Enrichment Corporation. Mr. Youngblood is a founder of Pharos Capital Group. He is a graduate of Princeton University and the University of Texas Southwestern Medical School, and is a member of the Council on Foreign Relations.
Michael V. Mullen, President
Mike is an experienced operations and finance executive with substantial experience in the areas of laboratory sciences, finance and accounting. Mr. Mullen has been employed with the company for over six years in several different capacities. Prior to being appointed to President and Senior Executive Officer, he served as the company’s Chief Financial Officer and Controller where he managed finance, accounting, information technology, billing, reimbursement, and human resources, and he was heavily involved with the commercial side of the company’s business. He holds dual degrees in accounting and laboratory science.
Robert Shufflebarger, Chief Operating Officer
Bob has more than 20 years of experience with life science and technology companies in areas of operations, finance, and marketing. He joined Atherotech in 2000 as one of the first 15 employees and led the scale-up of operations including increasing capacity more than 100 fold. Prior to Atherotech, Bob managed marketing and business development activities for Southern Research Institute, a contract research organization based in Birmingham, AL. He also worked at Southern Biotechnology Associates and at Avanti Polar Lipids, both privately held specialty chemical manufacturers in Birmingham. Bob holds a B.S. in Chemistry from Birmingham-Southern College and an MBA from Duke University.
Scott Rezek, Vice President of Commercial Operations
Scott has lead sales and marketing initiatives for several industries including health care and technology. Prior to Atherotech, Scott managed a $300M global sales channel at Invitrogen, now Life Technologies (NASDAQ: LIFE), a global biotechnology tools company. Before Invitrogen, Scott worked at San Francisco-based retailer Williams-Sonoma and at Course Technology, a Boston-based publishing subsidiary of the Thomson Corporation. Scott started his professional career as an Account Executive providing account management and overall client support for clients like Sony and Digital/Compaq. He holds a bachelor's from the University of West Florida and a master's from Auburn University.
Michael E. Cobble, MD, Chief Medical Officer
Mike is a board certified clinical lipidologist and fellow of the National Lipid Association. He runs a private practice in Salt Lake City where he has lived for more than 20 years and focuses on dyslipidemia, diabetes, cardiovascular diseases (CV), hypertension and primary care medicine. Cobble’s practice is also currently a referral clinic for the Harvard Bipolar Research Group encompassing mood and behavior care. He is the director of the Canyons Medical Center and on the board of directors for the Utah Healthy Living Foundation. Along with clinical patient care, Cobble is engaged with clinical research and medical education and is a member of the American Academy of Family Practice, the National Lipid Association, and the American Society of Hypertension. His published articles include topics on pathophysiology and treatment of diabetes. Cobble graduated with honors from the family practice program medical school/residency at The University of Utah School of Medicine. A large part of his practice involves cardiovascular risk assessments, vascular imaging, and the implementation of CV risk reduction strategies.
